[Drug therapy of ankylosing spondylitis].
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000494:pharmacology* / Q000627:therapeutic use; D008528:Mefenamic Acid / Q000627:therapeutic use; D008875:Middle Aged; D010653:Phenylbutazone / Q000494:pharmacology / Q000627:therapeutic use*; D011883:Radium / Q000009:adverse effects / Q000627:therapeutic use*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy* / Q000532:radiotherapy; D013910:Thorium / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D008528:Mefenamic Acid; D013910:Thorium; D010653:Phenylbutazone; D011883:Radium; D007213:Indomethacin
La thérapeutique médicamenteuse de la spondylarthrite ankylosante.